Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 4, 2016, Pages 723-730

  Philippe, Michael ^a   Ranchon, Florence ^a,b   Gilis, Lila ^a   Schwiertz, Vérane ^a   Vantard, Nicolas ^a   Ader, Florence ^c,d   Labussiere Wallet, Hélène ^a   Thomas, Xavier ^a   Nicolini, Franck Emmanuel ^a,d   Wattel, Eric ^a   Ducastelle Leprêtre, Sophie ^a   Barraco, Fiorenza ^a   Lebras, Laure ^a   Salles, Gilles ^a   Michallet, Mauricette ^a   Rioufol, Catherine ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

BK virus; Cidofovir; Hematopoietic stem cell transplantation; Hemorrhagic cystitis

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; CIDOFOVIR; CREATININE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; METHOTREXATE; MYCOPHENOLATE MOFETIL; PROBENECID; TACROLIMUS; VALGANCICLOVIR; ANTIVIRUS AGENT; CYTOSINE; MYELOABLATIVE AGENT; PHOSPHONIC ACID DERIVATIVE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BK VIRUS; BK VIRUS INFECTION; BLOOD TOXICITY; BONE MARROW TOXICITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOPENIA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MEDICAL LITERATURE; MEDLINE; MIDDLE AGED; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYOFIBROSIS; NAUSEA AND VOMITING; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; PARALLEL DESIGN; PRESCRIPTION; PROTEINURIA; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT RESPONSE; VIREMIA; YOUNG ADULT; ADVERSE EFFECTS; ALLOTRANSPLANTATION; ANALOGS AND DERIVATIVES; CYSTITIS; DRUG ADMINISTRATION; DRUG EFFECTS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; IMMUNOLOGY; MORTALITY; PATHOLOGY; PHYSIOLOGY; POLYOMAVIRUS INFECTIONS; PROCEDURES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TUMOR VIRUS INFECTIONS; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BK VIRUS; CYSTITIS; CYTOSINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; ORGANOPHOSPHONATES; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS; VIRAL LOAD;

EID: 84960471296     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.12.009     Document Type: Article

References (54)

1. Dropulic L.K., Jones R.J. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 2008, 41:11-18.
2. Leung A.Y., Suen C.K., Lie A.K., et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001, 98:1971-1978.
3. Shakiba E., Yaghobi R., Ramzi M. Prevalence of viral infections and hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Exp Clin Transplant 2011, 9:405-412.
4. Cesaro S., Facchin C., Tridello G., et al. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 41:363-370.
5. Leung A.Y., Yuen K.Y., Kwong Y.L. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005, 36:929-937.
6. Hirsch H.H. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005, 41:354-360.
7. Silva Lde P., Patah P.A., Saliba R.M., et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010, 95:1183-1190.
8. El-Zimaity M., Saliba R., Chan K., et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood 2004, 103:4674-4680.
9. Delbue S., Ferraresso M., Ghio L., et al. A review on JC virus infection in kidney transplant recipients. Clin Dev Immunol 2013, 2013:926391.
10. Bennett S.M., Broekema N.M., Imperiale M.J. BK polyomavirus: emerging pathogen. Microbes Infect Inst Pasteur 2012, 14:672-683.
11. Giraud G., Bogdanovic G., Priftakis P., et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006, 91:401-404.
12. Harkensee C., Vasdev N., Gennery A.R., et al. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation-a systematic review and evidence-based guidance for clinical management. Br J Haematol 2008, 142:717-731.
13. Cesaro S., Hirsch H.H., Faraci M., et al. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis 2009, 49:233-240.
14. Rinaldo C.H., Hirsch H.H. Antivirals for the treatment of polyomavirus BK replication. Exp Rev Anti Infect Ther 2007, 5:105-115.
15. Held T.K., Biel S.S., Nitsche A., et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000, 26:347-350.
16. Andrei G., Snoeck R., Vandeputte M., De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997, 41:587-593.
17. Randhawa P., Farasati N.A., Shapiro R., Hostetler K.Y. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother 2006, 50:1564-1566.
18. Bernhoff E., Gutteberg T.J., Sandvik K., et al. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant 2008, 8:1413-1422.
19. Mandell G.L., Benett J., Dolin R. Principles and practice of infectious diseases. Antiviral drugs (other than antiretrovirals) 2005, Churchill Livingstone, Philadelphia, PA.
20. Cundy K.C., Li Z.H., Lee W.A. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits. Drug Metab Dispos Biol Fate Chem 1996, 24:315-321.
21. Bedi A., Miller C.B., Hanson J.L., et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995, 13:1103-1109.
22. Gorczynska E., Turkiewicz D., Rybka K., et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005, 11:797-804.
23. Bridges B., Donegan S., Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006, 81:535-537.
24. Savona M.R., Newton D., Frame D., et al. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 2007, 39:783-787.
25. Faraci M., Cuzzubbo D., Lanino E., et al. Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. Pediatr Infect Dis J 2009, 28:55-57.
26. Rao K.V., Buie L.W., Shea T., et al. Intravesicular cidofovir for the management of BK virus-associated cystitis. Biol Blood Marrow Transplant 2009, 15:391-392.
27. Ganguly N., Clough L.A., Dubois L.K., et al. Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. Transpl Infect Dis 2010, 12:406-411.
28. Gaziev J., Paba P., Miano R., et al. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant 2010, 16:662-671.
29. Koskenvuo M., Dumoulin A., Lautenschlager I., et al. BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: treatment response and evidence for nosocomial transmission. J Clin Virol 2013, 56:77-81.
30. Kwon H.J., Kang J.H., Lee J.W., et al. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience. Transpl Infect Dis 2013, 15:569-574.
31. Gilis L., Morisset S., Billaud G., et al. High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2014, 49:664-670.
32. Lee S.S., Ahn J.S., Jung S.H., et al. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation. Korean J Intern Med 2015, 30:212-218.
33. Rascon J., Verkauskas G., Pasauliene R., et al. Intravesical cidofovir to treat BK virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation. Pediatr Transplant 2015, 19:E111-E114.
34. Dharnidharka V.R., Abdulnour H.A., Araya C.E. The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment. Pediatr Nephrol Berl Ger 2011, 26:1763-1774.
35. Nagafuji K., Aoki K., Henzan H., et al. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2004, 34:909-914.
36. Brody S.R., Humphreys M.H., Gambertoglio J.G., et al. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Clin Pharmacol Ther 1999, 65:21-28.
37. Momper J.D., Zhao Y., Shapiro R., et al. Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. Transpl Infect Dis 2013, 15:34-41.
38. O'Donnell P.H., Swanson K., Josephson M.A., et al. BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. Biol Blood Marrow Transplant 2009, 15:1038-1048.
39. Vats A., Shapiro R., Singh Randhawa P., et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003, 75:105-112.
40. Hatakeyama N., Suzuki N., Kudoh T., et al. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003, 22:928-929.
41. Kuypers D.R., Vandooren A.K., Lerut E., et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005, 5:1997-2004.
42. Kuypers D.R., Bammens B., Claes K., et al. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J Antimicrob Chemother 2009, 63:417-419.
43. Araya C.E., Lew J.F., Fennell R.S., et al. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant 2008, 12:790-795.
44. Lamoth F., Pascual M., Erard V., et al. Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. Antivir Ther 2008, 13:1001-1009.
45. Focosi D., Maggi F., Pistolesi D., et al. Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature. Leuk Res 2009, 33:556-560.
46. Mackey M.C. Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis. Ann Pharmacother 2012, 46:442-446.
47. Erard V., Storer B., Corey L., et al. BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis. Clin Infect Dis 2004, 39:1861-1865.
48. Portolani M., Pietrosemoli P., Cermelli C., et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988, 9:205-218.
49. Randhawa P.S. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005, 41:1366-1367.
50. Leung A.Y., Chan M.T., Yuen K.Y., et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:528-537.
51. Miller A.N., Glode A., Hogan K.R., et al. Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011, 17:1176-1181.
52. Toptas T., Kaygusuz-Atagunduz I., Kani H.T., et al. Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of three cases. Oncol Lett 2014, 8:1775-1777.
53. Wu J.K., Harris M.T. Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy. Ann Pharmacother 2008, 42:1679-1685.
54. Painter W., Robertson A., Trost L.C., et al. First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. Antimicrob Agents Chemother 2012, 56:2726-2734.